Antiidiotypic antibodies for high molecular weight-melanoma associated antigen
US5866124A · kind A · utility
23Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1996 |
| Grant date | Feb 2, 1999 |
| Priority date | — |
| Expiry date | May 22, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns antiidiotypic antibodies comprising human constant regions, and murine variable regions bearing the internal image of human high molecular weight-melanoma associated antigen which have the specificity of said antibody. These antiidiotypic monoclonal antibodies have immune-regulatory functions and can therefore be used for diagnostic and therapeutic purposes, such as the treatment of melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.